Clinical trialNCT01709474TerminatedPhase 2Interventional

Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment7Systemic Lupus Erythematosus

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of this study is to evaluate the effects of 18 weeks of high-dose vitamin D3 supplementation compared with standard-dose vitamin D3 supplementation on immune function, glucose homeostasis, and bone metabolism in children with systemic lupus erythematosus (SLE) and serum 25-hydroxyvitamin D \[25(OH)D\] levels ≤20 ng/mL.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Emily Von Scheven, MD, MAS
University of California, San Francisco
Study Chair
clinicaltrials.gov ↗
Jon M Burnham, MD, MSCE
University of Pennsylvania
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Children'S Hospital Los Angeles
Los Angeles, California, United States
Lucile Packard Children'S Hospital, Stanford University
Palo Alto, California, United States
Ucsf School of Medicine
San Francisco, California, United States
Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Riley Hospital for Children
Indianapolis, Indiana, United States
Columbia University
New York, New York, United States
University of Rochester
Rochester, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
the Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Children'S Medical Center of Dallas
Dallas, Texas, United States
Seattle Children'S Hospital
Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Vitamin D3

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2013
Primary completion: 31 Jul 2014
Completion: 31 Jul 2014
Last update posted: 17 Dec 2015
Registered enrollment: 7
Registry id: NCT01709474

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.